TSX-V: GENX
About
Team
Contact
Ophthalmics
OTC’s
Investors
AGM Notices
Financials
Research & Development
Products
News
Subscribe
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Genix Announces TSX-V Approval of Warrant Amendments
Genix Announces Warrant Repricing and Seeks Extension
Genix Announces AGM Results
Genix Announces Change of Auditor
Genix Announces Auditor Resignation
Genix Receives Approval to Extend Warrants from the TSX Venture Exchange
Genix Proposes to Extend Warrants
Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
1
2
3
Next
Menu